5 Mad Money Stock Picks This Week

3. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 84

Jim Cramer discussed several healthcare stocks in his recent program and said that the latest market rotation out of the healthcare sector had no justifiable reason. He said that he spent some time looking at why healthcare stocks like Johnson & Johnson (NYSE:JNJ) and Merck were down but he could not find any reason. Cramer said the only reason these stocks fell is because it was the end of the month and a lot of funds were unloading their “losers.”

Earlier this month, latest data showed Johnson & Johnson (NYSE:JNJ) treatment’s long-term durable efficacy and safety in Crohn’s disease.

Johnson & Johnson (NYSE:JNJ) has upped its dividend for six decades without a break. This makes Johnson & Johnson (NYSE:JNJ) one of the best for recession scenarios.

Johnson & Johnson (NYSE:JNJ) is also one of the most popular stocks owned by hedge funds as of the end of the last quarter of 2022. 84 out of the 943 funds tracked by Insider Monkey had stakes in Johnson & Johnson (NYSE:JNJ). The total value of these stakes was $5.6 billion.